COMPANIES

No Data Found

NEWS

No Data Found
Parenteral Drugs (India) Ltd
Parenteral Drugs (India) Ltd

Parenteral Drugs (India) Ltd (PDPL) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 1,063
Aug 21, 2023 Closed
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
2.90
0.00 (0.00%)
2.70Low
Today’s Performance
2.90High
-Low
52 Week’s Performance
2.90High

bt_logoStock Performance

  • 1 Day-%
  • 1 Week-%
  • 1 Month-3.33%
  • 3 Months-3.33%
  • 6 Months-23.68%
  • 1 Year-14.71%
  • 3 Years2.41%
  • 5 Years-22.16%

bt_logoPeer Comparison

Parenteral Drugs (India) Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
Price

bt_logoFinancial Analysis

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

bt_logoRatio Analysis

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

bt_logoDeals

06 Mar, 2014BUY
SYSTEMATIX FINVEST PRIVATE LIMITED
Qty627959
Average Price33.5
06 Mar, 2014SELL
RDMK IMPEX PRIVATE LIMITED
Qty627959
Average Price33.5
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

bt_logoFAQ's

What was Parenteral Drugs (India) Ltd share price previously?
Parenteral Drugs (India) Ltd share price was down by 0.00% from the previous closing price of ₹2.90.
Who are peers of Parenteral Drugs (India) Ltd?
The peers of Parenteral Drugs (India) Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Parenteral Drugs (India) Ltd?
The promotor/promotors of Parenteral Drugs (India) Ltd are Manoharlal Gupta, Govind Das Garg, Dharam Pal Khanna, Dilip Kumar Sinha, Anil Mittal, Manish Verma, Vinod Kumar Gupta, Deepali Garhewal, Chhaya Gupta.
What has been 52-week high of Parenteral Drugs (India) Ltd stocks?
The highest price of Parenteral Drugs (India) Ltd stock is ₹0.00 in the last 52-week.
What is the share price of Parenteral Drugs (India) Ltd (PDPL) today on NSE?
As on Aug 21, 2023 Parenteral Drugs (India) Ltd (PDPL)’s share price on NSE is Rs 2.9
What is the market cap of Parenteral Drugs (India) Ltd (PDPL)?
The current market capitalisation of Parenteral Drugs (India) Ltd (PDPL) is 8.65 crores
What is Parenteral Drugs (India) Ltd Share symbol?
The symbol of Parenteral Drugs (India) Ltd is PDPL.
What is the PE ratio of Parenteral Drugs (India) Ltd (PDPL)?
The current PE ratio of Parenteral Drugs (India) Ltd (PDPL) is -.
What is the PB ratio of Parenteral Drugs (India) Ltd (PDPL)?
The current PB ratio of Parenteral Drugs (India) Ltd (PDPL) is -0.01.
Today’s High & Low share prices of Parenteral Drugs (India) Ltd (PDPL) on NSE?
Today, the share price of Parenteral Drugs (India) Ltd (PDPL) on NSE touched a high of Rs 2.9 and a low of Rs 2.7
What price did Parenteral Drugs (India) Ltd (PDPL) shares open on the NSE today?
On NSE, the share price of Parenteral Drugs (India) Ltd (PDPL) opened at Rs 2.7
What is the 52-week high of Parenteral Drugs (India) Ltd (PDPL)?
The 52-week high price of Parenteral Drugs (India) Ltd (PDPL) is Rs 2.90
What is the 52-week low of Parenteral Drugs (India) Ltd (PDPL)?
The 52-week low price of Parenteral Drugs (India) Ltd (PDPL) is Rs -

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.